Thus, CE appears to have modulating effects on lipid metabolism through decreasing the mRNA levels of lipogenesis genes as well as increasing the mRNA level of CPT1A, involved in fatty acid oxidation, suggesting that CE may be an effective anti-NAFLD agent. The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatotic liver disease.